Skip to main content
. 2026 Jan 9;27:24. doi: 10.1186/s12859-025-06337-4

Table 2.

Performance in predicting drug indications. Reported is AUPRC

Category KL JS Proximity DSD RGCN HAN HGT BioBERT TxGNN COMIC
Random 0.50 0.49 0.53 0.49 0.84 0.87 0.72 0.81 0.91 0.9375
Cell proliferation 0.51 0.50 0.47 0.51 0.47 0.65 0.61 0.83 0.92 0.9031
Mental health 0.50 0.50 0.44 0.50 0.55 0.61 0.56 0.64 0.89 0.9046
cardiovascular 0.49 0.50 0.50 0.50 0.41 0.63 0.60 0.66 0.64 0.8817
Anemia 0.47 0.53 0.49 0.51 0.42 0.67 0.53 0.64 0.96 0.9302
Adrenal gland 0.48 0.50 0.48 0.50 0.38 0.59 0.54 0.64 0.99 0.9375
Autoimmune 0.51 0.49 0.56 0.52 0.51 0.53 0.49 0.66 0.87 0.9284
Metabolic disorder 0.51 0.54 0.41 0.51 0.67 0.56 0.54 0.68 0.76 0.9362
Diabetes 0.50 0.52 0.47 0.52 0.40 0.67 0.62 0.69 0.87 0.9114
Neurodegenerative 0.50 0.51 0.49 0.51 0.84 0.71 0.60 0.57 0.95 0.9182